Patients
colorectal cancer, colorectal peritoneal metastases, CRS
COLORECTAL CANCER
Eligible patients were adults with a World Health Organization performance status of 0–1, pathologically proven isolated resectable colorectal peritoneal metastases, no systemic therapy for colorectal cancer within 6 months prior to enrolment, and no previous CRS–HIPEC.